When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...
Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...
In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...
Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...
Elvis Picardo is a regular contributor to Investopedia and has 25+ years of experience as a portfolio manager with diverse capital markets experience. Samantha (Sam) Silberstein, CFP®, CSLP®, EA, is ...
Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...
A former Arvada teacher arrested Monday for reportedly creating and selling child sexual assault material was found to have violated St. Vrain Valley School District policies in 2023 for interactions ...
30 years ago, the blizzard of 1996 buried Lehigh Valley. Its memory still haunts The blizzard of 1996 was one of the most powerful snowstorms ever to hit the Lehigh Valley, dumping a then-record 25.6 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback